semaglutide and optic neuropathy A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Can Semaglutides (Ozempic) Cause Blindness?

Understanding why a patient may respond differently to non-GLP-1 agents requires evaluating both clinical factors and underlying metabolic markers

In a pre-specified blinded extension for those with a BMI 35, participants who continued on retatrutide 12 mg to 104 weeks lost an average of 85.0 lbs (30.3%).2 Additionally, retatrutide showed significant improvements from baseline across certain cardiovascular risk factors, including waist circumference, non-HDL cholesterol, triglycerides, systolic blood pressure and high-sensitivity C-reactive protein (hsCRP)

Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR,

29 , 34053420.e3405 (2019)

Esta titulacin gradual es esencial para minimizar los efectos secundarios gastrointestinales y permitir que el cuerpo se adapte al medicamento

Obtaining it through unregulated sources raises serious patient safety and legal concerns